fbpx ECRAN Project: a cartoon to describe clinical trials | Page 88 | Science in the net

ECRAN Project: a cartoon to describe clinical trials

Read time: 1 min

In 1747, there were many conflicting ideas and questions without answers about the cure for scurvy, a lethal kind of disease at the time. James Lind, surgeon of the Scottish navy, decided to face such an uncertainty by subjecting his patients to a clinical study, in order to compare six possible remedies. This experimentation showed that oranges and lemons were by far the best cure. His work not only saved the life of his ship's sailors, but also laid the foundations for modern clinical trials (randomized and controlled), as we know them today.

This is the reason why Lind's adventure starts the informative video on independent clinical research, realized by the European Communication Research Awareness Needs (ECRAN). The European project ECRAN, coordinated by the Istituto Mario Negri of Milan, in collaboration with eminent international partners, aims to disseminate information on independent clinical research within European citizens, through the realization of different kinds of informative and educational products. The cartoon produced by the project only lasts 5 minutes, is translated in 23 languages, is highly funny and captivating, and helps the public to understand the procedures followed during a clinical trial. International and independent clinical trials represent a fundamental contribute to clinical research, in order to find proper response on diagnosis, operations and prognosis.

[video: http://vimeo.com/69337236#at=0]

Autori: 
Sezioni: 
Ecran Project

prossimo articolo

Molecular machines, an already written future

In a world in which chemists assemble devices and machines billion times smaller than the usual ones, it is possible to develop systems similar to those created by nature within cells. The intricate arrangement of cellular organelles and enzymatic systems, muscle contraction, intracellular transport and ATP synthesis are examples of biological motors. For chemists this is a real challenge; to design active nanostructures that can operate as molecular machines, to increase our understanding of biological nanomotors and to construct a new generation of devices capable, for